Skip to main content

Kylie Heering, Weeks 5-8

Time really flew by! I'm wrapping up my work here in the lab. I'll miss everything about this summer so much--even washing and rinsing my membrane six times before imaging! These past few weeks have been very productive. I've worked on a lot of Western blots, gave more presentations at our lab meetings, and presented my final poster alongside Blake. Its been super busy and exciting, its sad that it has to come to an end.

I'll include some random bits and pieces from recently:

Preston took me to image some organoids on the microscope. The pictures are really cool. Its interesting to see the diversity of organoids from cells of the same sort. Basal and luminal-derived organoids have different morphologies as well, which is pretty awesome. Its amazing how these three dimensional tissue models can retain their identities in culture like this.
Luminal-derived organoid

I also learned how to quantify my Western blot data. The images obtained from performing Western blots are a qualitative analysis of protein level expression, so its advantageous to give the results a numerical identity. To do this, I used the program ImageJ.

I usually do chemiluminescent detection, but I did fluorescent detection for the first time!

Also, a project that I've found pretty fascinating tests if a drug is reversible. If so, it could lead to experiments regarding oncogene transduction because it maintains the phenotype of organoid culture during lentiviral infection.

I've been studying global methylation and its role in prostate epithelial cell differentiation.

I'm currently trying to hone a PNGase protocol to deglycolsylate proteins.

I'm learning a ton about metabolism, the mechanisms behind cancer, and everything in general (Thanks to Preston's napkin notes!)

My poster session went really well! I presented a collection of my research in characterizing mouse prostate epithelial cell-derived organoids to my lab. I even had the privilege of presenting my work to the head of UCLA's biomedical research minor. With my love for research reinforced by my summer EXP experience, I would be overjoyed to have the privilege to participate in that program if given the opportunity to attend UCLA! I got to watch Blake present her poster as well. Its awesome to see how much we both accomplished this summer.




While the best part of my summer is happening inside the lab, I've had a pretty exciting time outside of UCLA. These past few weeks I've explored a lot of California state.

Rohit and Alan came down to LA one weekend, so we did a two-day tour of LA. Even though I'd like to think I'm an LA local by now, my touristy-side came out when we went to the Hollywood Walk of Fame and Santa Monica Pier.

The next weekend I went up to San Francisco. I got to see a little bit Berkeley and Stanford--different campuses but both are very nice. I saw Michelle, Abby, and even KJ (which was amusingly unplanned). Rohit and Alan took me to the top spots to see in San Francisco. I finally got to see the Golden Gate Bridge, which has been on my bucket list for quite some time! And we went to Fisherman's Wharf. Boats are cool, I guess.


This last weekend Preston, Hector, Blake and I went down to San Diego. Preston and his friend tried to teach me how to surf (I stood up on the board--success!)


I visited the Hammer, an art museum here in Westwood with some of my friends.
Labels:

Comments

Post a Comment

Popular posts from this blog

Kylie Heering, Week 2 at the Goldstein Lab

We started off our week with a congratulatory acai bowl trip to celebrate Preston’s acceptance into a training grant program. Acai bowls in California top Playa Bowls (no question about it). From what I can tell, its a pretty huge honor to be recognized by this grant, but he’s really humble about it. On Monday, Preston and I decided that testing antibodies that have never been tested on prostate epithelial cells before would be a good objective for my first Western blot on my own. We needed to probe for ASCT2, a glutamine transporter, and GLS in order to determine if their corresponding antibodies are functional. Antibodies are crucial for Western blots because they bind to the protein of interest (POI), allowing for us to qualify its expression after imaging. As such, Preston wanted to make sure they worked by probing for ASCT2 and GLS on three different cell lines. Cell lines are commercially purchased human cells that have been immortalized (modified to grow indefinitely) by telome...
Post a Comment
Read more

Alan - First Week at UCSF

Hi Everyone! After arriving in San Francisco last Sunday, I spent this past week settling into the downtown Berkeley apartment that I’ll be sharing with Rohit for the next couple of months, as well as learning my way around the Roy lab at UCSF. First day at the lab was really exciting. Here are a couple pictures of the Mission Bay campus, which was completed just a few years ago. Everything is super new and modern, and there’s still construction for other buildings going on around the campus. Most of the people who work at the Mission Bay campus are either professional researchers or doctors/nurses for the nearby hospital. The graduate students take most of their classes at the original Parnassus campus (where Maya is). I work in Byers Hall, which is connected to Genentech Hall and a short walk down the block from the shuttle stop. There are three other volunteers working for the Roy lab this summer – Kimmai, David, and Pujita, who are all undergrad college students...
1 comment
Read more

Jaewon Oh - Week 7 and 8

Finally done here with my experience and I wish I had more time keep researching so that I have something a little more "finalised" to present. But I guess that's what past EXP kids meant when they said that 8 weeks of research is not enough and I'll have to work with what I've got. To solve the problem of not having enough data points, we used the online TCGA database for raw data that would be used to calculate mutation rates. Mutation rates were calculated through an R coding script that Dr. Cannataro had made. Because the mutation rates were tumor specific, we had to change the proportions that were obtained from the IARC database using data from another database called cBioPortal. Basically we had to multiply the number of times a certain variant was seen in the IARC database by the percentage of tumors that have a tp53 mutation, because our mutation rates are calculated across all tumors in specific cancers (confusing, I know). After graphing the mutatio...
Post a Comment
Read more